Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors

Clinical trial NCT00002994 · COMPLETED

Trial details

NCT number: NCT00002994
Sponsor: Alliance for Clinical Trials in Oncology
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1997-07-01
Primary completion: 2000-03-01
Enrollment: 355

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.